Digital Digital Therapeutics Market Overview by Region, Analysis, and Outlook (2023-2030) | |
The Global Digital Digital Therapeutics Market size was reasonably estimated to be approximately USD 6050 Million in 2023 and is poised to generate revenue of over USD 12880 Million by the end of 2030, projecting a CAGR of around 20.41% from 2023 to 2030. Digital therapeutics refers to the use of digital technologies, like smartphone apps, wearable devices, and software programs, to provide evidence-based therapeutic interventions for treating and managing various health conditions therapeutics involve interactive tools and platforms that offer educational content, behaviour-change techniques, and real-time monitoring of a patient's health data. They can be used alongside traditional medical treatments to enhance their effectiveness or as independent interventions. The goal of digital therapeutics is to provide personalized, accessible, and cost-effective solutions for patients. Examples include cognitive behavioral therapy apps for mental health, mobile applications for managing diabetes, or virtual reality programs for pain management. These interventions are developed based on scientific evidence and undergo rigorous testing to ensure their safety and efficacy. To Learn More About This Report, Request A Free Sample Copy: https://pristineintelligence.com/request-sample/digital-therapeutics-market-22 Top Key Players Covered in the Therapeutics Market: Omada Health Inc. (US), ResMed (US), Pear Therapeutics Inc. (US), Solera Network (US), Akili Interactive Labs Inc. (US), Better Therapeutics LLC (US), Biofourmis (US), Click Therapeutics Inc. (US), Naturalcycles Nordic AB (Sweden), NuvoAir AB (Sweden), Welldoc’s Bluestar (US), Happify Inc. (US), Limbix Health Inc. (US), Voluntis (US), Xealth (US) | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target Prov.: All Provinces Target City : usa Last Update : Feb 15, 2024 6:54 AM Number of Views: 85 | Item Owner : akshay patil Contact Email: Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |